Both in Pharmaceuticals
MetaVia vs Actuate Therapeutics
Over the past year MTVA returned −89.6% and ACTU returned −94.9%; their daily moves had a correlation of 0.07.
MTVA −89.6% ACTU −94.9%Growth of $1, one year, split-adjusted
| Metric | MTVA | ACTU |
|---|---|---|
| Price | $1.12 | $0.3351 |
| Market cap | $7.4M | $8.0M |
| Today | −5.88% | −9.68% |
| 1 month | −27.3% | −62.3% |
| 6 months | −22.2% | −88.8% |
| Year to date | −86.7% | −94.5% |
| 1 year | −89.7% | −94.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.8M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 61.9% | 162.1% |
| Short % of float | 2.9% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).